RxDoctor Payments Data

Marcine Schreckengost

Nurse Practitioner · Fresno, CANPI 1154591444

Payments from drug & device makers

$7,113in general payments, 2019–2025

Across 258 payments — averaging $27.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$3K
  • Abbott$2K
  • Boehringer Ingelheim$420
  • Lexicon Pharmaceuticals, Inc.$354
  • Merck$347
  • Novartis$293
  • plus $1K from 14 others

What the payments were for

  • Food & beverage$7,113100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,113 in reported general payments places this provider in the 95th percentile of 6,779 nurse practitioner providers in California.

See all nurse practitioner providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
EntrestoSacubitril/Valsartan204$317,863
EliquisApixaban88$102,555
JardianceEmpagliflozin36$54,160
FarxigaDapagliflozin Propanediol29$36,852
Repatha SureclickEvolocumab29$26,158
BrilintaTicagrelor17$20,968
InpefaSotagliflozin13$8,733
Ranolazine ErRanolazine35$5,969
Losartan Potassium105$1,414
Metoprolol Succinate74$1,286
Amiodarone Hcl28$1,278
Carvedilol71$741
Rosuvastatin Calcium27$736
Ezetimibe28$708
Amlodipine Besylate77$637

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$293$317,863204 claims
PfizerEliquis$102$102,55588 claims
AstraZenecaFarxiga, Brilinta$66$57,82046 claims
Boehringer IngelheimJardiance$420$54,16036 claims
Lexicon Pharmaceuticals, Inc.Inpefa$354$8,73313 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,779 nurse practitioner providers in California.

Other nurse practitioner in Fresno

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →